Ermenegildo Zegna NV
ZGN
Cars.com
CARS
Lantheus
LNTH
New Fortress Energy
NFE
eBay
EBAY
US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 115.630
- +4.550+4.10%
Close Jan 23 16:00 ET
- 115.630
- 0.0000.00%
Post 17:49 ET
7.35BMarket Cap-55.33P/E (TTM)
116.120High111.260Low1.48MVolume111.260Open111.080Pre Close169.58MTurnover2.35%Turnover RatioLossP/E (Static)63.53MShares121.90052wk High23.46P/B7.27BFloat Cap72.24052wk Low--Dividend TTM62.86MShs Float125.610Historical High--Div YieldTTM4.38%Amplitude13.040Historical Low114.604Avg Price1Lot Size
Blueprint Medicines News
Blueprint Medicines | 10-Q: Q3 2024 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT® / AYVAKYT ® (avapritinib) Full Year Revenue Guidance
Blueprint Medicines | 10-Q: Q2 2024 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Second Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Blueprint Medicines | 10-Q: Q1 2024 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT ® / AYVAKYT ® (avapritinib) Full Year Revenue Guidance
Blueprint Medicines | 10-K: FY2023 Annual Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
Blueprint Medicines | 10-Q: Q3 2023 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Third Quarter 2023 Results
Blueprint Medicines | 10-Q: Q2 2023 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Second Quarter 2023 Results
Blueprint Medicines | 10-Q: Q1 2023 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports First Quarter 2023 Results
Blueprint Medicines | 10-K: FY2022 Annual Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results
Blueprint Medicines | 10-Q: Q3 2022 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale and Reports Third Quarter 2022 Financial Results at Investor Day 2022
Blueprint Medicines | 10-Q: Q2 2022 Earnings Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Second Quarter 2022 Results
